Abstract
Background
Our prospective study of patients with early T-stage head and neck cancer indicated a high incidence of newly diagnosed secondary malignancies during the follow-up period. We aimed to determine the incidence rate and risk factors of secondary malignancies in early-stage head and neck cancer patients.
Methods
We sub-analyzed the patient data of a previous study focusing on secondary cancer incidence. The endpoints were statistical analyses of risk factors and survival and incidence rates.
Results
The incidence rate of secondary cancer was 37%, the crude incidence of second primary cancers was 10.6 per 100 person-years, and the 5 year secondary cancer-free survival rate was 63%. The hypopharynx as the primary site was an independent significant predictive factor (odds ratio 3.96, 95% confidence interval 1.07–14.6, p = 0.039).
Conclusions
Early stages of laryngeal, oropharyngeal, and hypopharyngeal cancer had a risk of secondary cancer, especially hypopharyngeal cancer. Attention to the secondary cancer has to be paid during the follow-up period after controlling the early-stage disease. These findings highlight the need for awareness of the incidence of secondary cancer in cases of early-stage primary head and neck cancer.
Similar content being viewed by others
Availability of data and materials
The datasets used during the present study are available from the corresponding author upon request. All data generated or analyzed during this study are included in this published article.
References
Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan. https://ganjoho.jp/reg_stat/
Vikram B (1984) Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 110:564–565
Vokes EE, Kies M, Haraf DJ et al (1995) Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. J Clin Oncol 13:876–883
Khuri FR, Lippman SM, Spitz MR et al (1997) Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst 89:199–211
Dammann F, Horger M, Mueller-Berg M et al (2005) Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR Am J Roentgenol 184:1326–1331
Watanabe A, Taniguchi M, Tsujie H et al (2008) The value of narrow band imaging endoscope for early head and neck cancers. Otolaryngol Head Neck Surg 138:446–451
Morita M, Saeki H, Ito S et al (2014) Surgical strategies for esophageal cancer associated with head and neck cancer. Surg Today 44:1603–1610
Nishimura G, Sano D, Arai Y et al (2019) A prospective clinical trial of the second-look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer. Cancer Med 8:7197–7206
Nishimura G, Sano D, Yabuki K et al (2017) The second-look procedure for transoral videolaryngoscopic surgery for T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer patients: protocol for nonrandomized clinical trial. JMIR Res Protoco 6:e235
Bhatia AK, Lee JW, Pinto HA et al (2017) Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: long-term follow-up of a trial of the eastern cooperative oncology Group-ACRIN Cancer Research Group (C0590). Cancer 123:4653–4662
Rogers SN, Swain A, Carroll C et al (2019) Incidence, timing, presentation, treatment, and outcomes of second primary head and neck squamous cell carcinoma after oral cancer. Br J Oral Maxillofac Surg 57:1074–1080
Ord RA, Isaiah A, Dyalram D et al (2018) Is long-term follow-up mandatory for stage i oral tongue cancer? J Oral Maxillofac Surg 76:2676–2683
Sobin L, Wittekind C (2009) TNM Classification of malignant tumours, 7th edn. Wiley-Liss, New York
Cooper JS, Pajak TF, Rubin P et al (1989) Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 17:449–456
McDonald S, Haie C, Rubin P et al (1989) Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment, and prevention. Int J Radiat Oncol Biol Phys 17:457–465
Licciardello JT, Spitz MR, Hong WK (1989) Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 17:467–476
Lee DW, Roh JL, Baek S et al (2013) Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 149:579–586
Xiang M, Chang DT, Pollom EL (2020) Second cancer risk after primary cancer treatment with three-dimentional conformal, intensity-modulated, or proton beam radiation therapy. Cancer 126(15):3560–3568
Shinozaki T, Katada C, Shiga K et al (2020) Effectiveness of planned surveillance for detecting second primary head and neck cancers after endoscopic resection of esophageal squamous cell carcinoma. Jpn J Clin Oncol. https://doi.org/10.1093/jjco/hyaa087[Epub ahead of print]
Yokoyama A, Kumagai Y, YokoyamaT, et al (2009) Health risk appraisal models for mass screening for esophageal and pharyngeal cancer: an endoscopic follow-up study of cancer-free Japanese men. Cancer Epidemiol Biomarkers Prev 18:651–655
Yamashita Y, Ikegami T, Suzuki M et al (2019) Hypopharyngeal cancer risk in Japanese: genetic polymorphisms related to the metabolism of alcohol- and tobacco-associated carcinogens. J Cancer Res Ther 15:556–563
Lippman SM, Hong WK (1989) Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17:691–694
The Cancer Institute Hospital of JFCR, Japan. https://www.jfcr.or.jp
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
GN and NO conceived and statistical analyzed this study, and edited this manuscript. GN, NO, DS and YA designed this study. GN, TH, HT, YK, KT and TW acquired, analyzed and interpreted the date. GN, DS and YA evaluated the quality control of data and algorithms. GN prepared this manuscript and all authors reviewed and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflicts of interest.
Ethics approval and consent to participate
Ethical approval for the study was obtained from the Yokohama City University Institutional Review Board (#B131107003). Written informed consent was obtained from the study participants to publish of their data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Nishimura, G., Sano, D., Arai, Y. et al. The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer. Int J Clin Oncol 26, 59–65 (2021). https://doi.org/10.1007/s10147-020-01779-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-020-01779-7